Money and Transplantation

Loading...

Из курса от партнера University of Cape Town

Organ Donation: From Death to Life

59 оценок

University of Cape Town

Organ Donation: From Death to Life

59 оценок

Considering someone for organ and tissue donation at the end of life is complicated. The boundary between life and death is more complex than ever before and it falls to medical professionals to help clarify a situation at an often confusing and emotionally stressful time. In this course you will learn about the science behind death determination and when it is possible for deceased organ donation take place. The lectures will cover medical standards at the end of life - from brain death testing, to requesting informed consent from a grieving family. By improving knowledge of good ethical practices, cultural and religious considerations and the logistics of the organ donation process this course will empower the interactions and discussions of medical professionals and the general public at an often confusing time. This course will help you to ensure that the option of organ donation is compassionately explored in all appropriate situations at the end of life in the best way possible. Watch the course trailer here https://www.youtube.com/watch?v=Ak-kVtmZGRs The course is certified for continuing professional development (CPD) points in South Africa. Send your completion certificate to organdonation@uct.ac.za together with your HPCSA number for 25 general and 5 ethics points. For another interesting course on organ donation and transplantation, see Clinical Kidney, Pancreas and Islet Transplantation from Leiden University https://www.coursera.org/learn/clinical-kidney-transplantation

Из урока

Ethical Issues in Transplantation

Congratulations! You've reached the final week of the course Organ Donation: From Death to Life. Many factors influence organ donation rates across the world - from religion and culture to where you live and what resources are available. In our final week we will take a look at the role of money and travel in organ transplantation and show you the steps being taken to stamp out organ trafficking and transplant tourism. Dr Boitumelo Nkgudi a colleague of mine from Department of Surgery will speak to us on the influence that different religions and cultures have on organ donation. Organ donation comes with a lot of stigma and religious and cultural competence is essential to connecting with potential donor families before asking for consent for organ donation. We will end off our last week by looking at how to assess the true potential of deceased organ donation, what deceased organ donation models exist, and possible strategies to improve them including improving public awareness. Nobody can do everything when it comes to transplantation - but everybody can do something… Enjoy the last week of the course.

Introduction to Week 41:16

Money and Transplantation7:30

Travel and Transplantation3:22

Organ Trafficking7:20

Познакомьтесь с преподавателями

David Thomson
Dr
Critical Care Specialist and Transplant Surgeon

[MUSIC]

Healthcare cost money.

An organ transplantation is expensive.

The freely given gift of deceased organ donation

requires us to take a close look at fair access to healthcare.

Access to healthcare is a basic human right, and

one that I believe the world should be united in striving towards.

But the reality is we as individuals and as countries are for various reasons,

only able or willing to pay a certain amount towards our healthcare.

For example, I pay for private medical insurance because it improves my family's

access to healthcare resources in South Africa.

Does this improve our access to transplantation?

Directly not at all, the entire population competes for what is an exceptionally scarce

resource allocated on medical needs, matching, and time spent waiting.

Indirectly however, my family would have a better chance of being accepted onto

the waiting list for the transplant.

Because of better access to healthcare resources along the wait to transplantation.

Financial constraints can effect transplantation outcomes

even in the system where access to dialysis is universal, and paid for

by the government, such as in the United States.

Post-transplant immunosuppressive therapy is only funded by the government

for the first three years following a transplant.

After that, someone else has to pay.

Immunosuppression is expensive and a life long requirement of the transplantation.

Patients with private insurance in the United States have been shown to do better

than those without because their transplant lasts longer.

Partly on the basis of reliable access the immunosuppressive medication.

The vast majority of the world battles with adequate primary healthcare

provision.

On a cost effectiveness scale,

this is the most efficient health intervention to uplift the society.

Vaccinations, reproductive health, and

infectious disease treatments can save millions of lives.

This means that transplantation is often not prioritized as a major health need.

The single biggest individual drug expense in my hospital is for

a specific immunosuppressive drug that can be used to prevent rejection.

Cost is a barrier to transplantation for many countries.

And after low donation rates,

it's the second biggest factor affecting access to transplantation.

I firmly believe that deceased organ donation rates and

transplantation activity in a country is a reflection of the state of your entire

healthcare system.

It reflects how we treat patients at the end of their life.

Are they given a fighting chance with ICU support?

Is the family appropriately counselled at the end of life?

And I'll be able to support patients with organ failure well enough

to successfully transplant them.

Transplantation is similar to how an apex predator

can reflect to health of the whole ecosystem.

If you're in tight ecosystem is not broad based and functioning well.

You cannot naturally support apex predators such as lions.

If you want to see a marker of how healthy your ecosystem or healthcare system is,

just see how many lions, or transplants it can sustain.

No donor family is ever required to pay the cost of organ donation.

When death is certified, transplant team takes over

all the cost related to donor management, organ recovery, and organ transport.

What is important is that this process is not commercialized.

No one can profit along the way.

All transplant organizations are required to be non-profit.

And there are government regulations requiring them to maintain audible records

of their practices.

There are some economic models looking at legally regulated commercialization of

living and related kidney transplantation.

Given the overall cost savings, to a society of transplantation over dialysis.

Iran is the only country with such a system currently in place.

Where donors are remunerated over and above the cost of donation.

This has social implications for transplantation activity with the burden

of donation being shifted on to people of lower socioeconomic groups.

Most countries strive for financial neutrality in living transplantation

to prevent living donors from incurring costs related to organ donation.

In Canada, for example, living donors are given lifelong health insurance.

Disease donors do not put their life at risk and have no need for

ongoing health insurance.

Some countries will offer families assistance towards funeral costs but

it is important such support is regulated and not so

excessive as to be considered a perverse incentive to donate.

In South Africa, disease donation is totally altruistic,

and no money is handed over to the family.

Probably, one of the most famous people, definitely the richest to receive

a transplant, was Steve Jobs, the co-founder of Apple.

His reason for needing a liver transplant was the uncommon indication of metastatic

neuroendocrine cancer of the pancreas.

In his home state of California he was competing against a much larger pool

of potential recipients.

Steve Jobs was able to be listed in multiple jurisdictions for

his liver transplant on the basis that he could fly to the required center on short

notice if a liver became available.

He ended up receiving his liver transplant in Memphis Tennessee.

Steve Jobs was the most appropriate recipient for

that donor on that waiting list at that time.

He didn't jump the queue, but

he was able to be in more queues than an average person.

This is obviously not an option is available to everyone.

However, is accepted with the new American system.

Some countries such as South Africa, only allow you to be on one transplant list.

But that doesn't mean people inside Africa don't need money to travel for transplant.

The reality for patients inside Africa is they often have to relocate.

Be closer to a transplant center in a major urban city

in order to maximize their chances of receiving an organ.

They also maximize the chance of the operation being a success, because they

can get to the hospital quicker, and limit the colder ischaemic time.

And they can be followed up more closely by a specialized transplant team.

We recently did a transplant for

a patient living in Kuruman in the Northern Cape province in South Africa.

A 10.5 hour drive from our transplant center in Cape Town.

Luckily for our patient the logistics of the transplant all worked out in the end.

But that might not have been the case.

The socioeconomic status of recipients does influence transplant outcomes.

The life long immunosuppression required to prevent rejection carries risks,

not the least of which is infection.

In order to be listed for a transplant in South Africa,

you need access to basic sanitation and housing.

A flushing toilet, running water, and

a roof over your head are directly linked to transplant outcomes.

So much, so that the risk of dying from an infectious complication

related to immunosuppression could offset the gain from receiving a transplant.

To die from a diarrheal illness secondary to your immunosuppression

following a transplant is a tragedy.

For me, this once again shows how transplantation is a benchmark of

even more than just our healthcare system.

It is a reflection on a society in general.

Over and above ensuring that money does not directly influence the allocation of

organs.

We need to establish fear and equal access to organ transplantation for all patients.

[MUSIC]

Ознакомьтесь с нашим каталогом

Присоединяйтесь бесплатно и получайте персонализированные рекомендации, обновления и предложения.

Coursera делает лучшее в мире образование доступным каждому, предлагая онлайн-курсы от ведущих университетов и организаций.

© Coursera Inc., 2018 Все права защищены.

Загрузить из App Store

Загрузить в Google Play